Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9X87
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $132,440
Award facts
- Contract value 100% obligated
- $132,439.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $132,439.68 to AmerisourceBergen Drug Corp for the supply of Opdivo 240 mg/24 ml vials. This non-competitive, firm fixed-price delivery order is scheduled for completion by February 6, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million and extending through December 31, 2031. This primary IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of prescription medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities to federal agencies, particularly the Defense Logistics Agency and Defense Health Agency. The company's extensive federal contracting history demonstrates capability in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains through competitively awarded contracts. Opdivo, a specialty oncology medication, aligns with the company's established portfolio of brand-name pharmaceutical products supplied to military treatment facilities and veterans' healthcare systems, reinforcing its role as a strategic pharmaceutical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9X87?
SPE2DR26F9X87 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9X87 worth?
The government has obligated $132,440 on SPE2DR26F9X87.
Is contract SPE2DR26F9X87 an order under another contract?
Yes. SPE2DR26F9X87 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9X87 competed?
The extent of competition for SPE2DR26F9X87 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award